IGF1 and neoplasm: The tumor-to-blood ratio provided by [68Ga]Ga-NODAGA-(HE)3-ZIGF-1R:4551 is higher than the ratio provided by [111In]In-IGF-1(E3R) at 4 h after injection (5.8) [37].